Trial Details

COMPLETED
Basic Information
Clinical ID c4610
Identifier NCT00265122
Trial Title A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn Disease
Interventions DRUG: Ustekinumab 90 mg|DRUG: Ustekinumab 4.5 mg/kg|DRUG: Placebo SC|DRUG: Placebo IV
Participant Information
Sponsor Centocor, Inc.
City Scottsdale
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2004-04
Primary Completion Date 2005-11
Completion Date 2006-10